*SCALPSWINGSTRADDLE*

[Zephyr]

The following are some of today's most notable movers of interest, categorized by market capitalization (large cap over $10 billion and mid cap between $2-10 billion) and ranked by % change (all stocks over 100K average daily volume).

Large Cap Gainers
UPS (100.15 +3.23%): Said it expects to hire between 90,000 and 95,000 seasonal employees to support the anticipated increase in package volume that will begin in November.
FCAU (14.77 +3.07%): Reported that its European sales increased 13.9% in August, announced that its current contract with the UAW will be extended on an hour by hour basis as bargaining continues.
AA (9.59 +2.24%): Announced a collaboration with Ford (F) under which it will use Alcoa's Micromill material in multiple components on the 2016 F-150; also announced a worldwide licensing deal with Danieli Group to commercialize its Micromill technology.

Large Cap Losers
VOD (33.67 -1.81%): Liberty Global's (LBTYA) John Malone out saying still unable to agree on terms with Vodafone regarding a potential deal.
PHG (25.23 -1.45%): Provided and update on its performance and strategy in the HealthTech market at its Capital Markets Day; expects modest sales growth for 2015.

Mid Cap Gainers
SDRL (7.06 +9.29%): Announced it has exercised its right to cancel the contract for the construction of the West Mira, has the ability to recoup the $168 mln in pre-delivery instalments.
OI (21.48 +6.97%): Upgraded to Buy at BofA/Merrill.
GWPH (113.58 +6.25%): Announced positive top line results from an exploratory Phase 2a placebo-controlled clinical trial of Cannabidiol in 88 patients with schizophrenia who had previously failed to respond adequately to first line anti-psychotic medications; over a series of exploratory endpoints, CBD was consistently superior to placebo.

Mid Cap Losers
PEB (36.6 -5.08%): Reported weaker than anticipated hotel demand during August and September; sees Q3 RevPAR growth at low end of guidance; reaffirmed Q3 AFFO guidance.
FOLD (17.56 -3.68%): Announced it will submit an NDA for its migalastat for the treatment of Fabry disease after holding a Pre-NDA meeting with the FDA.
LHO (30.69 -2.94%): REITs underperforming as treasury yields jump (DRH, SHO, RLJ, MPW, also lower).